IFNB1 and colorectal carcinoma: This result might be relevant for immunotherapy development because it has recently been shown that IFN-β can sensitize CRC cells to 5-fluorouracyl treatment with a potent effect on the reduction of tumor mass, suggesting a novel strategy to selectively target CRC34.